4//SEC Filing
BAKER DOUGLAS P 4
Accession 0001213900-21-047223
CIK 0001448431other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:46 PM ET
Size
10.0 KB
Accession
0001213900-21-047223
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
BAKER DOUGLAS P
Chief Financial Officer
Transactions
- Sale
Common Stock (pursuant to 10B5-1 plan)
2021-09-07$70.53/sh−2,232$157,423→ 48,564 total - Exercise/Conversion
Stock Option
2021-09-08$7.51/sh−10,000$75,100→ 44,699 totalExercise: $7.51From: 2020-06-30Exp: 2022-03-31→ Common Stock (10,000 underlying) - Sale
Common Stock (pursuant to 10B5-1 plan)
2021-09-08$67.25/sh−10,000$672,500→ 48,564 total - Exercise/Conversion
Common Stock
2021-09-08$7.51/sh+10,000$75,100→ 58,564 total
Footnotes (2)
- [F1]These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001028775
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 4:46 PM ET
- Size
- 10.0 KB